PFE Oct 2024 18.000 put
| Previous Close | 0.0200 |
| Open | 0.0100 |
| Bid | 0.0000 |
| Ask | 0.0200 |
| Strike | 18.00 |
| Expire Date | 2024-10-18 |
| Day's Range | 0.0100 - 0.0200 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 383 |
- Investing.com
Pfizer gains as CEO said to meet activist Starboard
Pfizer Inc. (NYSE:PFE) shares rose more than 3% on Wednesday following reports that CEO Albert Bourla is scheduled to meet with executives from activist hedge fund Starboard Value next week. The news reported by the Financial Times comes after a recent report from Reuters that said Starboard had taken a stake of approximately $1 billion in the pharmaceutical giant and is pushing for changes aimed at revitalizing the company's performance. According to the Financial Times, the meeting, which includes Pfizer's lead independent director Shantanu Narayen, who also serves as CEO of Adobe Systems (NASDAQ:ADBE), will involve discussions with Starboard’s chief executive Jeff Smith and Patrick Sullivan, head of its healthcare investments.
Barrons.comPfizer and CVS Are Attracting Activists. Healthcare Stocks Could Rebound.
FEATURE The smart money seems to be calling a bottom for the healthcare sector. That could mean it’s time for investors to start taking another look at the industry’s more beleaguered stocks. Since the ...
ZacksPfizer (PFE) Stock Drops Despite Market Gains: Important Facts to Note
In the closing of the recent trading day, Pfizer (PFE) stood at $29.18, denoting a -0.07% change from the preceding trading day.
